Lancaster, SOUTH%20CAROLINA3 Active Studies

Lung Cancer Clinical Trials in Lancaster, SOUTH%20CAROLINA

Find 3 actively recruiting lung cancer clinical trials in Lancaster, SOUTH%20CAROLINA. Connect with local research sites and explore new treatment options.

3
Active Trials
2
Sponsors
1,167
Enrolling

Recruiting Lung Cancer Studies in Lancaster

RecruitingLancaster, SOUTH%20CAROLINANCT04928846

A Study to Assess Disease Activity and Adverse Events of Intravenous (IV) Telisotuzumab Vedotin Compared to IV Docetaxel in Adult Participants With Previously Treated Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. Non-small cell lung cancer (NSCLC) is a solid tumor, a disease in which cancer cells form in the tissues...

698 participants
AbbVie
View Study Details
RecruitingLancaster, SOUTH%20CAROLINANCT04929041

Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative

This phase II/III trial compares the addition of radiation therapy to the usual treatment (immunotherapy with or without chemotherapy) versus (vs.) usual treatment alone in treating patients with non-...

427 participants
National Cancer Institute (NCI)
View Study Details
RecruitingLancaster, SOUTH%20CAROLINANCT05198830

Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer

This phase II trial tests whether TRC102 (methoxyamine hydrochloride) in combination usual care treatment comprised of pemetrexed, cisplatin or carboplatin, and radiation therapy followed by durvaluma...

42 participants
National Cancer Institute (NCI)
View Study Details

About Lung Cancer Clinical Trials in Lancaster

Lung cancer is the leading cause of cancer death worldwide, starting in the cells of the lungs. The two main types are non-small cell lung cancer (NSCLC) and small cell lung cancer (SCLC). Treatments include surgery, chemotherapy, radiation, immunotherapy, and targeted drugs.

There are currently 3 lung cancer clinical trials recruiting participants in Lancaster, SOUTH%20CAROLINA. These studies are seeking a combined 1,167 participants. Research is being sponsored by AbbVie, National Cancer Institute (NCI). Clinical trial participation is free and participants receive study-related medical care at no cost.

Lung Cancer Clinical Trials in Lancaster — FAQ

Are there lung cancer clinical trials in Lancaster?

Yes, there are 3 lung cancer clinical trials currently recruiting in Lancaster, SOUTH%20CAROLINA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Lancaster?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Lancaster research site will contact you about next steps.

Are clinical trials in Lancaster free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Lancaster studies also compensate for your time and travel.

What lung cancer treatments are being tested?

The 3 active trials in Lancaster are testing new therapies including novel drugs, biologics, and treatment approaches for lung cancer.

Data updated March 2, 2026 from ClinicalTrials.gov